Fig 1: Depletion of Rorc does not Induce Spontaneous Behavioral Changes in Male Mice. (A) Loss of gene expression of both Il17 and Rorc in in vitro skewed Th17s from Rorc KO mice and littermate controls by qPCR (n = 3–4/group). T tests (il17: p = 0.0450, Rorc: p = 0.0281). (B) ELISA representing loss of IL-17 in in vitro skewed Th17s from Rorc KO animals (n = 3–4/group). T test (p = < 0.0001). (C) Baseline marble burying (n = 9 or 16/group), (D) sucrose preference (n = 9/group) and forced swim and tail suspension (n = 22 or 37/group), (E) social preference (n = 9 or 19/group), (F) nestlet shredding (n = 22 or 28/group), elevated plus maze (n = 24 or 31/group) and open field (n = 22 or 31/group), and (G) novel object recognition (n = 9 or 19/group) tests. T tests used in D and F. Two-way ANOVA used in E (Cre Neg: p = 0.0010, Cre Pos: p < 0.0001) and G (Cre Neg: p = 0.0014, Cre Pos: p = 0.0002). (H) Kullback–Leibler divergence heatmap and (I) PCA plot of DeepLabCut analyzed behaviors between groups (n = 22 or 32/group). Combined N = 2, male mice.
Fig 2: Loss of Rorc in T cells does not Impact Depressive- or Anxiety- like Behaviors in Female Mice. No differences in (A) depressive-like (n = 12/group) or (B) anxiety-like (n = 12/group) behaviors between female Rorc KO and littermate controls at baseline. No differences in the (C) Kullback–Leibler divergence heatmap or (D) PCA plot of DeepLabCut analyzed baseline behaviors between groups (n = 12/group). (E) Depressive-like (n = 12/group) and (F) anxiety-like (n = 12/group) behaviors after 3 weeks of UCRS between female Rorc KO and littermate controls (Nestlet Shred: p = 0.0392, Elevated Plus Maze: p = 0.0453). (G) Kullback–Leibler divergence heatmap and (H) PCA plot of DeepLabCut analyzed behaviors after 3 weeks of UCRS between groups (n = 12/group). T tests, N = 1, female mice.
Fig 3: GPR183 and 7a,25-OHC Promote ILC3 Localization to CPs and ILFs(A) Distribution of Gpr183+/+ and Gpr183-deficient hematopoietic cells in the colon of mixed bone marrow chimeras. Bone marrow cells from Gpr183+/+ or Gpr183-/- mice (CD45.2+) were mixed 9:1 with B6 cells (CD45.1+) and injected into irradiated Rag1-/- recipients (CD45.1+) for the generation of bone marrow chimeras. Sections were stained for detection of Gpr183+/+ and Gpr183-/- cells (CD45.2, red) or B6 cells (CD45.1, green). Nuclei were visualized by DAPI staining (blue). Scale bars on the right (white) represent 100 µm.(B) Distribution of Gpr183+/+ and Gpr183-deficient ILCs in the colon of mixed bone marrow chimeras. Bone marrow cells from Gpr183+/+ or Gpr183-/- mice (CD90.2+) were mixed 9:1 with B6 cells (CD90.1+) and injected into irradiated B6 recipients (CD90.1+) for the generation of bone marrow chimeras. Colon sections were stained for detection of Gpr183+/+ and Gpr183-/- (CD90.2, red) or B6 (CD90.1, green) ILCs. Scale bars (red) represent 100 µm. The lower panel shows the number of clusters in Gpr183+/+-B6 and Gpr183-/--B6 chimeras consisting of CD90.2+ (red) or CD90.1+ (green) ILCs. Data are represented as means ± SEM. p value by two-way ANOVA.(C and D) Distribution of donor-derived ILC3s (ROR?t-GFP+, green) in the colon (C) and small intestine (D) of bone marrow chimeras. Bone marrow cells from Rag1-deficient Rorc(?t)GFP transgenic mice were injected into irradiated Ch25h+/+ or Ch25h-/- recipients for the generation of bone marrow chimeras. Sections were co-stained for detection of B cells (B220+, red). Scale bars (red) represent 100 µm. The lower panel in (C) shows the number of donor-derived ILC3s in the colon of Ch25h+/+ or Ch25h-/- hosts. Data are representative of or combined from two (B–D) or three (A) experiments. See also Figure S5.
Fig 4: ILC3-Expressed GPR183 Is Required for the Formation of Colonic Lymphoid Tissues(A) Distribution of GFP+ cells in the small intestine and colon of Gpr183GFP/+ mice. Tissue sections were co-stained with a-CD90.2 and a-B220 Abs. Scale bars (white) represent 100 µm.(B) Number of CPs and ILFs in the small intestine and colon of Rorc(?t)GFPGpr183+/+ and Rorc(?t)GFPGpr183-/- mice (n = 3–5). The upper panel shows representative images of a CP and an ILF from Rorc(?t)GFPGpr183+/+ mice. Scale bars (red) represent 100 µm.(C) Number of peripheral and mesenteric lymph node cells (n = 6–8), Peyer’s patches (n = 10), and colonic patches (n = 3) from Gpr183+/+ and Gpr183-/- mice.(D) Number of ROR?t+ clusters in the colon of bone marrow chimeras (n = 5–9). Bone marrow cells from Gpr183+/+ or Gpr183-/- mice were injected into either Gpr183+/+ or Gpr183-/- irradiated recipient mice.(E) Number of CPs in the colon of Rag1-deficient Gpr183+/+ and Gpr183-/- mice (n = 5).(F) Number of CPs, ILFs, Peyer’s patches, and colonic patches in Rorc-cre Gpr183flox/flox mice and Gpr183flox/flox or Gpr183flox/+ controls (n = 3–6).Data are represented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by Student’s t test or one-way ANOVA with Tukey’s post-test (D). Data are representative of or combined from two (F) or three (A–E) experiments. See also Figures S3 and S4.
Fig 5: LTi-like ILC3s Highly Express GPR183 and Migrate toward 7a,25-OHC(A) Gpr183 mRNA expression in the indicated cell populations from the spleen (n = 2–6). mRNA expression was normalized to Hprt.(B) GFP expression in lamina propria B cells and ILC subsets from the colon of Gpr183GFP/+ reporter mice (green histograms) and B6 control mice (gray histograms).(C) Left panel illustrates high GPR183-GFP expression in CD4+ LTi-like ILC3s from the colon. Right panel shows mean fluorescence intensity (MFI) of GPR183-GFP expression in the indicated cell populations from (B) (n = 6).(D–F) Transwell migration of splenic LTi-like ILC3s (Lin-CD90.2+CD127+NK1.1-) from Rag1-deficient Gpr183+/+ and Gpr183-/- mice (D), splenic B cells from B6 mice and ILC subsets from Rorc(?t)GFPRag1-/- mice (E), and colonic ILC subsets from Rag1-/- mice (F) to 7a,25-OHC (n = 2–3).Data are represented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey’s post-test. Data are representative of or combined from two (D and E) or three (A–C and F) experiments. See also Figures S1 and S2.
Supplier Page from Thermo Fisher Scientific for ROR gamma (t) Antibody PE